CohBar (CWBR) USPTO patents

Utility

CXCR4 Antagonist Peptides

15 Dec 22

This disclosure relates to the fields of cell biology and the modulation of cell signaling associated with migration and localization of immune cells and aberrant cellular proliferation, migration, and malignancy.

Kenneth Cundy

Filed: 13 Nov 20

Utility

Peptide-containing formulations

6 Dec 22

A formulation comprising glutamic acid, or a salt thereof, and an effective amount of a peptide is provided.

Kenneth Cundy, Kent K. Grindstaff, Remi Magnan

Filed: 27 Mar 19

Utility

Therapeutic Mitochondrial Peptides

20 Oct 22

The disclosures herein relate to the fields of cell biology and the modulation of cellular mechanisms controlling cell viability, cell proliferation, and metabolic processes.

Kenneth Cundy

Filed: 12 Aug 20

Utility

Therapeutic Peptides

13 Oct 22

The disclosures herein relate to the fields of cell biology and the modulation of cellular mechanisms controlling cell viability, cell proliferation, and metabolic processes.

Kenneth Cundy

Filed: 14 Aug 20

Utility

Therapeutic Peptides

13 Oct 22

The disclosures herein relate to the fields of cell biology and the modulation of cellular mechanisms controlling cell viability, cell proliferation, and metabolic processes.

Kenneth Cundy

Filed: 14 Aug 20

Utility

Therapeutic Peptides

13 Oct 22

The disclosures herein relate to the fields of cell biology and the modulation of cellular mechanisms controlling cell viability, cell proliferation, and metabolic processes.

Kenneth Cundy

Filed: 14 Aug 20

Utility

Therapeutic Peptides

13 Oct 22

The disclosures herein relate to the fields of cell biology and the modulation of cellular mechanisms controlling cell viability, cell proliferation, and metabolic processes.

Kenneth Cundy

Filed: 17 Aug 20

Utility

Therapeutic Peptides

29 Sep 22

The disclosures herein relate to the fields of cell biology and the modulation of cellular mechanisms controlling cell viability, cell proliferation, and metabolic processes.

Kenneth Cundy

Filed: 17 Aug 20

Utility

Therapeutic Peptides

29 Sep 22

The disclosures herein relate to the fields of cell biology and the modulation of cellular mechanisms controlling cell viability, cell proliferation, and metabolic processes.

Kenneth Cundy

Filed: 17 Aug 20

Utility

Therapeutic Peptides

4 Aug 22

Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.

Kenneth Cundy, Remi Magnan, Kent K. Grindstaff, Wendy Luo, Yongjin Yao, Liang Zeng Yan

Filed: 11 Apr 22

Utility

Therapeutic Peptides

21 Jul 22

The disclosures herein relate to the fields of cell biology and the modulation of cellular mechanisms controlling cell viability, cell proliferation, and metabolic processes.

Kenneth Cundy

Filed: 28 Jan 20

Utility

Therapeutic peptides

17 May 22

Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.

Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan

Filed: 4 Aug 21

Utility

Therapeutic Peptides

25 Nov 21

Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.

Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan

Filed: 4 Aug 21

Utility

Therapeutic peptides

7 Sep 21

Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.

Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan

Filed: 27 Sep 17

Utility

Peptide-containing Formulations

4 Feb 21

A formulation comprising glutamic acid, or a salt thereof, and an effective amount of a peptide is provided.

Kenneth Cundy, Kent K. Grindstaff, Remi Magnan

Filed: 27 Mar 19

Utility

Therapeutic Peptides

10 Jun 20

Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.

Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan

Filed: 26 Sep 17